REGULATED PRESS RELEASE published on 06/04/2025 at 07:00, 1 year 5 months ago Biophytis announces its participation in the BIO International Convention from June 16 to 19 Biophytis announces participation in BIO International Convention from June 16 to 19, 2025 in Boston, USA. Focus on drug candidate BIO101 and potential partnerships Biophytis Biotechnology Partnerships BIO International Convention Drug Candidate
REGULATED PRESS RELEASE published on 06/04/2025 at 07:00, 1 year 5 months ago Biophytis annonce sa participation à la BIO International Convention du 16 au 19 juin Biophytis participera à la BIO International Convention du 16 au 19 juin 2025 à Boston, USA, pour présenter ses avancées et son candidat médicament BIO101 Biophytis Biotechnologie Boston BIO International Convention Maladies Liées À L'âge
BRIEF published on 05/30/2025 at 22:05, 1 year 5 months ago Biophytis reporte la publication de ses comptes annuels 2024 Biophytis Assemblée Générale Comptes Annuels Audit Report
BRIEF published on 05/30/2025 at 22:05, 1 year 5 months ago Biophytis Delays 2024 Annual Financial Report Publication Financial Statements Biophytis Shareholder Meeting Age-related Diseases Audit Delay
REGULATED PRESS RELEASE published on 05/30/2025 at 22:00, 1 year 5 months ago Information sur les comptes annuels Biophytis reporte la publication des comptes annuels 2024 en raison de complications techniques dans le processus d'audit. L'assemblée générale des actionnaires est également repoussée Biophytis Assemblée Générale Comptes Annuels Audit Report
REGULATED PRESS RELEASE published on 05/30/2025 at 22:00, 1 year 5 months ago Information on the Annual Financial Statements Biophytis postpones the publication of its 2024 annual financial statements due to technical complications in the audit process. The Company aims to complete the audit by the end of June 2025 Biophytis Audit Postponement 2024 Annual Financial Statements Technical Complications
PRESS RELEASE published on 05/30/2025 at 21:59, 1 year 5 months ago Information sur les comptes annuels Biophytis reporte la publication de ses comptes annuels 2024 en raison de complications techniques dans l'audit. L'assemblée générale est également reportée. La société se concentre sur le développement de traitements pour les maladies liées à l'âge Biophytis Développement Comptes Annuels Report Maladies Liées À L'âge
PRESS RELEASE published on 05/30/2025 at 21:59, 1 year 5 months ago Information on the Annual Financial Statements Biophytis postpones 2024 annual financial statements publication due to technical audit issues, reschedules General Meeting of shareholders following legal procedures Shareholders Financial Statements Biophytis Meeting Audit
BRIEF published on 05/15/2025 at 07:05, 1 year 5 months ago Biophytis Unveils Promising Obesity Treatment at ECO 2025 Biophytis Clinical Trials Obesity Treatment BIO101 ECO 2025
BRIEF published on 05/15/2025 at 07:05, 1 year 5 months ago Biophytis présente une avancée dans le traitement de l'obésité à l'ECO 2025 Biophytis Essai Clinique BIO101 Obésité GLP-1
Published on 11/06/2026 at 22:15, 2 days 9 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 18 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 07:10, 25 minutes ago Hypoport delivers solid gross profit growth and an increase in EBIT in the first nine months of 2026
Published on 11/09/2026 at 07:00, 35 minutes ago Sandoz launches new semaglutide treatment option in Brazil, expanding patient access to GLP-1 medicine in key global market
Published on 11/09/2026 at 07:00, 35 minutes ago Cicor receives awards for two major defence programmes
Published on 11/09/2026 at 01:55, 5 hours 40 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 19 hours 24 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/09/2026 at 07:00, 35 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 35 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 35 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 35 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 12 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
